USANA Health Sciences, Inc. (NYSE:USNA) ABR of 3

As per the methodology used by the respective brokerage firm, the analysts apply varied terminologies to release stock calls. Retail investors who come across new broker houses find it tough to understand their calls. So, Zacks fixes an analyst brokerage rating for giving the calls on a 1-5 scale. When the rating is one, it is an indication of a strong buy call and in case of 5, it is sell call.

Analysts have a buy call on USANA Health Sciences, Inc. (NYSE:USNA) stock. As of 2016-04-25, the stock has an ABR of 3. This rating comes on a scale of 1-5, where one makes a strong buy call, and 3 indicates Strong Sell. This ABR computation is done on basis of 1 recommendations.

USANA Health Sciences, Inc. (NYSE:USNA) has a 1-year mean target price of $130 and the median target is $130. The broad range of price target varies between $130 and $130, indicating a standard deviation of 0.

Zacks gives the average brokerage recommendation to numerous stocks for several investment sites. It is the mean of the actual calls given by the brokerage houses on a specified stock. This ABR is displayed in decimals while Zacks Rank is given in whole numbers.

Although the recommendation is listed on a 1-5 scale, it is a lot more different from the rank assigned by Zacks. This call is simply based on brokerage houses calls. Analysts of research firms stay overly confident with their given calls. For every “Strong Sell” stock call, brokerages place 5 “Strong Buy” recommendations. Even if brokerages show some value, they have largely not shown to be successful in prompting investors to the shares showing strong probably of growth.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 18 times, 1 visits today)